HCA Healthcare, Inc. (NYSE:HCA) to Issue $0.78 Quarterly Dividend

Key Points

• HCA declared a $0.78 quarterly dividend payable June 30 to shareholders of record on June 16, implying roughly a 0.7% yield; the company has raised its dividend each year for six years and has a low payout ratio (~11%), indicating earnings coverage.
• Q1 results and outlook: HCA reported EPS of $7.15 (a $0.04 miss) and revenue of $19.11B (+4.3% YoY), set FY2026 EPS guidance of $29.10–$31.50 (analysts expect $30.17), and its stock fell about $41 to $433 with a market cap near $96.8B and a trailing PE of ~15.3.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) declared a quarterly dividend on Friday, April 24th. Investors of record on Tuesday, June 16th will be given a dividend of 0.78 per share on Tuesday, June 30th. This represents a c) dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th.

HCA Healthcare has increased its dividend payment by an average of 0.3%annually over the last three years and has raised its dividend every year for the last 6 years. HCA Healthcare has a payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect HCA Healthcare to earn $33.21 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.4%.

HCA Healthcare Price Performance

NYSE HCA traded down $40.99 during trading hours on Friday, hitting $433.04. 3,308,531 shares of the company's stock traded hands, compared to its average volume of 1,095,514. The firm's 50-day moving average is $507.59 and its 200-day moving average is $485.06. HCA Healthcare has a 52-week low of $321.39 and a 52-week high of $556.52. The company has a market capitalization of $96.81 billion, a PE ratio of 15.26, a PEG ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the prior year, the firm earned $6.45 earnings per share. The company's revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare will post 30.17 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company's stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 over the last quarter. 1.50% of the stock is owned by corporate insiders.

Institutional Trading of HCA Healthcare

Several hedge funds have recently modified their holdings of HCA. State Street Corp raised its position in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company's stock valued at $3,532,563,000 after purchasing an additional 76,039 shares in the last quarter. Capital World Investors increased its stake in shares of HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company's stock worth $2,334,040,000 after buying an additional 40,086 shares during the period. Geode Capital Management LLC lifted its stake in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock worth $1,702,738,000 after acquiring an additional 13,565 shares during the last quarter. Norges Bank purchased a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company's stock worth $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.